Prabal K. Chatterjee
Impact in
- Nephrology top 0.5%
- Acute Kidney Injury Research
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Peroxisome Proliferator-Activated Receptors 7
- Heme Oxygenase-1 and Carbon Monoxide 5
- Nephrology 15
- Acute Kidney Injury Research 14
- Co-authors
- Christoph Thiemermann (49 shared papers)Salvatore Cuzzocrea (35 shared papers)Hélder Mota‐Filipe (18 shared papers)Keith N. Stewart (16 shared papers)Paul A. Brown (15 shared papers)Nimesh S. A. Patel (14 shared papers)Kai Zacharowski (10 shared papers)Michelle C. McDonald (11 shared papers)
- Journals
- Kidney International (13 papers)European Journal of Pharmacology (5 papers)Free Radical Biology and Medicine (4 papers)The FASEB Journal (3 papers)Molecular Pharmacology (3 papers)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Prabal K. Chatterjee
67 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 105
- Nephrology 709
- Biochemistry 343
- Pathology and Forensic Medicine 494
- Physiology 601
- Pharmacology 323
Countries citing papers authored by Prabal K. Chatterjee
This map shows the geographic impact of Prabal K. Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prabal K. Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prabal K. Chatterjee more than expected).
Fields of papers citing papers by Prabal K. Chatterjee
This network shows the impact of papers produced by Prabal K. Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prabal K. Chatterjee. The network helps show where Prabal K. Chatterjee may publish in the future.
Co-authors
The 25 scholars most cited alongside Prabal K. Chatterjee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 317 | |
| 2 | 2000 | 311 | |
| 3 | 2002 | 213 | |
| 4 | 2007 | 182 | |
| 5 | 2004 | 168 | |
| 6 | 2005 | 149 | |
| 7 | 2003 | 129 | |
| 8 | 2003 | 129 | |
| 9 | 2001 | 112 | |
| 10 | 2002 | 107 | |
| 11 | 2002 | 103 | |
| 12 | 2000 | 96 | |
| 13 | 2001 | 91 | |
| 14 | 2003 | 89 | |
| 15 | 2003 | 85 | |
| 16 | 1999 | 69 | |
| 17 | 2003 | 68 | |
| 18 | 2004 | 65 | |
| 19 | 2003 | 64 | |
| 20 | 2005 | 64 |
About Prabal K. Chatterjee
Prabal K. Chatterjee is a scholar working on Molecular Biology, Nephrology, Pathology and Forensic Medicine, Physiology and Cell Biology, having authored 67 papers that have together received 3.8k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (14 papers), Cardiac Ischemia and Reperfusion (12 papers), Nitric Oxide and Endothelin Effects (11 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Inflammatory mediators and NSAID effects (6 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers), Calpain Protease Function and Regulation (5 papers) and PARP inhibition in cancer therapy (5 papers). The work is most often cited by research in Nephrology (709 citations), Biochemistry (343 citations), Pathology and Forensic Medicine (494 citations), Physiology (601 citations) and Pharmacology (323 citations). Prabal K. Chatterjee has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Christoph Thiemermann, Salvatore Cuzzocrea, Hélder Mota‐Filipe, Keith N. Stewart, Paul A. Brown, Nimesh S. A. Patel, Kai Zacharowski, Michelle C. McDonald, Domenico Britti and Nicole S. Wayman. Their work appears in journals such as Kidney International, European Journal of Pharmacology, Free Radical Biology and Medicine, The FASEB Journal and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.